Chen Y - Search Results

1

The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease.

Bai X, Zhu J, Chen Y, Sun H. Bai X, et al. Among authors: chen y. Future Med Chem. 2024 Dec 24:1-16. doi: 10.1080/17568919.2024.2444875. Online ahead of print. Future Med Chem. 2024. PMID: 39717965 Review.

2

Butyrylcholinesterase-Activated Near-Infrared Fluorogenic Probe for In Vivo Theranostics of Alzheimer's Disease.

Wang L, Sun T, Zhen T, Li W, Yang H, Wang S, Feng F, Chen Y, Sun H. Wang L, et al. Among authors: chen y. J Med Chem. 2024 Apr 25;67(8):6793-6809. doi: 10.1021/acs.jmedchem.4c00355. Epub 2024 Mar 28. J Med Chem. 2024. PMID: 38546542

3

Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application.

Guan Q, Xing S, Wang L, Zhu J, Guo C, Xu C, Zhao Q, Wu Y, Chen Y, Sun H. Guan Q, et al. Among authors: chen y. J Med Chem. 2024 May 23;67(10):7788-7824. doi: 10.1021/acs.jmedchem.4c00652. Epub 2024 May 3. J Med Chem. 2024. PMID: 38699796 Review.

4

New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands.

Sun T, Zhen T, Harakandi CH, Wang L, Guo H, Chen Y, Sun H. Sun T, et al. Among authors: chen y. Eur J Med Chem. 2024 Sep 5;275:116569. doi: 10.1016/j.ejmech.2024.116569. Epub 2024 Jun 4. Eur J Med Chem. 2024. PMID: 38852337 Review.

5

Structural modification strategies of triazoles in anticancer drug development.

Guan Q, Gao Z, Chen Y, Guo C, Chen Y, Sun H. Guan Q, et al. Among authors: chen y. Eur J Med Chem. 2024 Sep 5;275:116578. doi: 10.1016/j.ejmech.2024.116578. Epub 2024 Jun 13. Eur J Med Chem. 2024. PMID: 38889607 Review.

6

NRF2 inhibitors: Recent progress, future design and therapeutic potential.

Lv B, Xing S, Wang Z, Zhang A, Wang Q, Bian Y, Pei Y, Sun H, Chen Y. Lv B, et al. Among authors: chen y. Eur J Med Chem. 2024 Dec 5;279:116822. doi: 10.1016/j.ejmech.2024.116822. Epub 2024 Sep 3. Eur J Med Chem. 2024. PMID: 39241669 Review.

7

Optical control of butyrylcholinesterase (BChE) activity via photoswitchable azobenzene for potential treatment of Alzheimer's disease.

Wang L, Gao Z, Sun T, Chen C, Zhu J, Wang S, Chen Y, Sun H. Wang L, et al. Among authors: chen c, chen y. Bioorg Chem. 2024 Dec;153:107845. doi: 10.1016/j.bioorg.2024.107845. Epub 2024 Sep 24. Bioorg Chem. 2024. PMID: 39348751

8

Can Targeted Protein Degradation Technology Provide a Potential Breakthrough in the Development of Anti-AD Drugs?

Xiong B, Song Z, Wang L, Zhang A, Zhou Y, Zheng N, Wei Y, Chen Y, Sun H. Xiong B, et al. Among authors: chen y. ACS Chem Neurosci. 2024 Oct 2;15(19):3434-3436. doi: 10.1021/acschemneuro.4c00590. Epub 2024 Sep 18. ACS Chem Neurosci. 2024. PMID: 39354828

9

New insight into targeting the DNA damage response in the treatment of glioblastoma.

Zhen T, Sun T, Xiong B, Liu H, Wang L, Chen Y, Sun H. Zhen T, et al. Among authors: chen y. Chin J Nat Med. 2024 Oct;22(10):869-886. doi: 10.1016/S1875-5364(24)60694-1. Chin J Nat Med. 2024. PMID: 39428180 Review.

10

A Pharmacokinetic-Pharmacodynamic Model of Tamoxifen and Endoxifen to Predict Their Distribution and Effects on Inhibition of Tumor Growth.

Yuan S, Sun Q, Chen Y, Liao J. Yuan S, et al. Among authors: chen y. Drug Metab Lett. 2017;11(2):93-101. doi: 10.2174/1872312811666170815160751. Drug Metab Lett. 2017. PMID: 28814243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179,747 results

Search Page

Filters